Product Information
PHENTERMINE 15 MG CAPSULE is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.1004 per EA under NDC 11534015703. Its NADAC has been published 372 times since May 15, 2019.
Strength
15 mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534015703
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205019On Market Since
1/24/2017
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 15 MG CAPSULE has been published 372 times since May 15, 2019, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1004 per EA |
|---|---|
| All-time high | $0.1766 (Jun 12, 2019) |
| All-time low | $0.0784 (Nov 20, 2024) |
| 52-week high | $0.1014 |
| 52-week low | $0.0828 |
| Median price | $0.1240 |
| Average price | $0.1232 |
| Largest weekly change | +44.3% (Aug 21, 2024) |
| Weeks tracked | 372 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 15 MG CAPSULE, manufactured by Sunrise Pharmaceutical Inc., is $0.1004 per EA (NDC 11534015703), effective Jun 24, 2026.
How has the price of PHENTERMINE 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 15 MG CAPSULE has declined 35.5%. It has been tracked across 372 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 15 MG CAPSULE?
Since May 15, 2019, the NADAC for PHENTERMINE 15 MG CAPSULE has ranged from a low of $0.0784 (Nov 20, 2024) to a high of $0.1766 (Jun 12, 2019), with a median of $0.1240 per EA.
Are there cheaper alternatives to PHENTERMINE 15 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PHENTERMINE 15 MG CAPSULE, but none are currently priced below it.
Who manufactures PHENTERMINE 15 MG CAPSULE?
PHENTERMINE 15 MG CAPSULE (NDC 11534015703) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification